Literature DB >> 31616079

Combined immunosuppression for ILD in myositis.

Joanna Collison1.   

Abstract

Entities:  

Year:  2019        PMID： 31616079     DOI： 10.1038/s41584-019-0328-1

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Authors:  Hideaki Tsuji; Ran Nakashima; Yuji Hosono; Yoshitaka Imura; Masato Yagita; Hajime Yoshifuji; Shintaro Hirata; Takaki Nojima; Eiji Sugiyama; Kazuhiro Hatta; Yoshio Taguchi; Masaki Katayama; Kiminobu Tanizawa; Tomohiro Handa; Ryuji Uozumi; Shuji Akizuki; Kosaku Murakami; Motomu Hashimoto; Masao Tanaka; Koichiro Ohmura; Tsuneyo Mimori
Journal:  Arthritis Rheumatol       Date:  2020-01-27       Impact factor: 10.995
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.